Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Investig Drugs. 2006 Aug;7(8):750-8.

Drug evaluation: Albuferon-alpha--an antiviral interferon-alpha/albumin fusion protein.

Author information

  • 1University of Connecticut Health Center, Department of Medicine, Division of Gastroenterology-Hepatology, Farmington, CT 06030-1845, USA.

Abstract

Human Genome Sciences Inc (HGS), in collaboration with Novartis AG, is developing Albuferon-alpha, a long-acting injectable human interferon alpha2b fusion protein, for the potential treatment of hepatitis C virus (HCV) infection. By May 2004, phase II clinical trials of Albuferon in HCV infection were underway. In June 2006, HGS planned to initiate phase III clinical trials in this indication by the end of 2006. Albuferon also has the potential to treat a broad range of cancers.

PMID:
16955687
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk